GL1X · GenesisL1 explorer

Research workbench

Crystal structure of checkpoint kinase 2 in complex with inhibitor PV1115

Analyse Crystal structure of checkpoint kinase 2 in complex with inhibitor PV1115 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2YCQ
Type
protein
Length
285 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase CHK2
EC
2.7.11.1
UniProt
O96017
Ligands
UPX, NO3
Pockets
3 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase CHK2 (EC 2.7.11.1)protein28540% helix, 16% strandO96017

Ligands and binding sites

  • UPX · N-{4-[(1E)-N-1H-imidazol-2-ylethanehydrazonoyl]phenyl}-7-nitro-1H-indole-2-carboxamide · ligand · chains A
  • NO3 · Nitrate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12520.610.8036UPX
2920.360.7417empty
3800.320.7319empty

Compared structures

  • 2YCQ · Crystal structure of checkpoint kinase 2 in complex with inhibitor PV1115 · the same entry in another collection · chain A against A, TM-score 1.00
  • O96017 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase CHK2 (O96017) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.